Intra-cellular Therapies, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBedminster, NJ
US patents167
SAM.gov UEIVA5JXLCJHDK7
CAGE code3CQL3
Incorporated inDE
LEI5299002U2KGF193IJA20
Brands
This company sells these brands.
- medicines
- disorders
- CAPLYTA
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
167 US patents granted 2012–2025, 76 of them in the five years to SEP 2025.
Pharmaceuticals 155Organic fine chemistry 9Measurement 1
- MethodsUS 12,414,948 · granted SEP 16, 2025
- Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disordersUS 12,410,195 · granted SEP 9, 2025
- CompoundsUS 12,410,175 · granted SEP 9, 2025
- Methods of treating acute depressionUS 12,409,176 · granted SEP 9, 2025
- Organic compoundsUS 12,396,992 · granted AUG 26, 2025
Newest 5 shown · Granted to Intra-cellular Therapies, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Intra-cellular Therapies, INC. | Bedminster | NJ | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.